Resilience

Resilience is a biomanufacturing Contract Development and Manufacturing Organization (CDMO) based in North America, established in 2020. The company is committed to enhancing access to complex medicines and safeguarding biopharmaceutical supply chains. Resilience specializes in high-tech manufacturing solutions that support the rapid and scalable production of advanced therapies, including biologics, vaccines, nucleic acids, cell therapies, and gene therapies. The company combines scientific and engineering expertise with advanced technologies to create flexible and regulatory-compliant manufacturing platforms. Resilience operates multiple facilities across the United States and Canada, with its Cincinnati facility serving as a key manufacturing hub. It caters to a diverse customer base, including small to mid-sized biotech companies and larger pharmaceutical firms, providing integrated services from drug substance to drug product manufacturing. Resilience's mission is to bridge the gap between scientific discoveries and the manufacturing technologies necessary for large-scale production of complex medicines.